UNSPSC 41202031: Hepatitis a virus (hav) serological assays

In this classification, Hepatitis a virus (hav) serological assays are devices used in test to identify specific Hepatitis a virus (hav) serological assays antibodies in serum. US FDA regulates Hepatitis a virus (hav) serological assays under 21 CFR 866.3310 and under FDA product code LOL.

UNSPSC 41202031 Hepatitis A virus (HAV) serological assays is a Commodity code that does not map to active state and local procurement activity in the recent opportunities block. The source records ten solicitations spanning February through July 2026 from Illinois Department of Public Health, Texas Department of Criminal Justice, Collin County, City of Austin, University of Houston, and Collier County, yet only one—the Illinois Department of Public Health's February 2026 IFB for Hepatitis/HIV/Syphilis 4th Gen Assay Screening and Instrument—explicitly names hepatitis testing within a broader multi-pathogen serological assay scope. The remaining nine opportunities address HIV and Syphilis testing reagents and supplies, forensic laboratory services, clinical diagnostics unrelated to serology, and pool maintenance services. The hepatitis-specific solicitation seeks a fully automated combination screening instrument capable of simultaneous testing for Hepatitis B antigen and antibody, Hepatitis C antibody, HIV-1/HIV-2 antigen and antibody, and Syphilis antibody, with annual volume of approximately 3,300 Hepatitis B tests, but the code's focus on HAV serology is not directly represented in the recent activity.

State and local procurement activity in related serological testing is concentrated in Texas and Illinois, with the Illinois Department of Public Health appearing as the dominant buyer across three separate records (emergency Abbott reagent procurements and the multi-pathogen assay IFB) and Texas agencies—Collin County Community Supervision and Corrections Department and the Texas Department of Criminal Justice—soliciting drug screening and forensic analysis services. The February 2026 Illinois IFB 26482DPHOFCDIB50489 represents the closest match to the code's nominal scope, seeking Hepatitis/HIV/Syphilis assay screening and instrumentation with a five-year base term and up to five years renewal, with bids due March 16, 2026; however, HAV serology does not appear as a standalone procurement focus across the available records, and the code shows limited discrete activity warranting targeted pursuit at this time.